Candel Therapeutics shares owned by ProShare Advisors
Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by ProShare Advisors
from 13F filings
Historical chart of ProShare Advisors investment in Candel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Candel Therapeutics held by ProShare Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Candel Therapeutics by ProShare Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $59k | 10k | 5.65 |